• Legend Biotech appointed Ingrid Zhang chief executive officer, effective September 15, 2026.
• Zhang succeeds Alan Bash, interim CEO since July 2026, who resumed his role as president, CARVYKTI.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001801198-26-000026), on November 10, 2026, and is solely responsible for the information contained therein.